Though data remain relatively sparse among pediatric patients, we recently reported that Ang-2 elevations are associated with mortality in pARDS and, additionally, that rising Ang-2 levels are highly predictive of mortality among hematopoietic stem cell transplant recipients (40). This evidence concerns the gene ANGPT2 and pediatric acute respiratory distress syndrome.